DCM
OCRX

DAFNA Capital Management’s Ocera Therapeutics, Inc. OCRX Stock Holding History

DAFNA Capital Management’s Portfolio OCRX Stock Details OCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-634,893
Closed -$4.04M – 81
2014
Q4 		$4.04M Sell
634,893
-40,757
-6% -$238K 3.2% 8
2014
Q3 		$3.31M Buy
675,650
+515,028
+321% +$2.97M 3.34% 8
2014
Q2 		$1.23M Buy
160,622
+97,399
+154% +$776K 1.16% 21
2014
Q1 		$667K Hold
63,223
– – 0.57% 34
2013
Q4 		$821K Buy
63,223
+55,329
+701% +$517K 0.85% 27
2013
Q3 		$67K Buy
+7,894
New +$63.6K 0.07% 51

Other funds holding OCRX

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return

DAFNA Capital Management's OCRX Position: Q1 2015 in Review

DAFNA Capital Management sold out of Ocera Therapeutics, Inc. (OCRX) in Q1 2015, closing a stake of 634,893 shares — an estimated $4.04M sold.

DAFNA Capital Management first reported a position in OCRX in Q3 2013 and held it in 6 quarters. The position peaked at $4.04M in Q4 2014. 34 funds tracked by Wall St. Rank hold OCRX as of Q1 2015.

  • DAFNA Capital Management reported no remaining Ocera Therapeutics, Inc. position as of Q1 2015 after selling out during the quarter.
  • DAFNA Capital Management sold 634,893 Ocera Therapeutics, Inc. shares in Q1 2015, an estimated $4.04M.
  • DAFNA Capital Management first reported a position in Ocera Therapeutics, Inc. in Q3 2013 and held it in 6 quarters.
  • DAFNA Capital Management's Ocera Therapeutics, Inc. position peaked at $4.04M in Q4 2014.
  • 34 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q1 2015.

Based on DAFNA Capital Management's 13F filing for Q1 2015, filed 15 May 2015.